Leon E. Chen
Direktor/Vorstandsmitglied bei Eikon Therapeutics, Inc.
Ursprung des Netzwerks ersten Grades von Leon E. Chen
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
University of California, Berkeley
549
| College/University | Other Consumer Services | 549 |
Stanford University
114
| College/University | Other Consumer Services | 114 |
Stanford Graduate School of Business
106
| College/University | Other Consumer Services | 106 |
The Column Group LLC
 The Column Group LLC Investment ManagersFinance The Column Group LLC is a venture capital firm founded in 2005 by Peter Svennilson. The firm is headquartered in San Francisco.
39
| Private Company | Investment Managers | 39 |
| Subsidiary | Pharmaceuticals: Major | 37 | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London.
25
| Subsidiary | Investment Managers | 25 |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Eikon Therapeutics, Inc.
 Eikon Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Eikon Therapeutics, Inc. operates as a biopharmaceutical company. The company is headquartered in Hayward, CA.
10
| Holding Company | Miscellaneous Commercial Services | 10 |
Remix Therapeutics, Inc.
 Remix Therapeutics, Inc. BiotechnologyHealth Technology Remix Therapeutics, Inc. operates as a biotechnology company. It involves in developing small molecule therapies which are designed to reprogram RNA processing to address the underlying drivers of disease. The company was founded by Pete Smith and is headquartered in Cambridge, MA.
7
| Holding Company | Biotechnology | 7 |
| Public Company | Pharmaceuticals: Major | 6 | |
Velia, Inc.
 Velia, Inc. Packaged SoftwareTechnology Services Velia, Inc. is a company based in San Francisco, CA that is focused on harnessing the therapeutic potential of a novel class of human peptides. These peptides regulate biological functions that are vital to human health. The company was founded by Alan Saghatelian, Jonathan Weissman, Eric Olson, and Richard Scheller. John G. McHutchison has been the CEO of the company since 2023.
5
| Holding Company | Packaged Software | 5 |
Skyline Management LLC
 Skyline Management LLC Investment ManagersFinance Skyline Management LLC (Skyline Management) is a venture capital firm founded in 1997 by John Gordon Freund. The firm is headquartered in Palo Alto, California.
2
| Private Company | Investment Managers | 2 |
Venrock Associates
 Venrock Associates Investment ManagersFinance Venrock Associates is an Independent Venture Capital firm founded in 1969. The firm is headquartered in Palo Alto.
1
| Private Company | Investment Managers | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Leon E. Chen
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
National Academy of Sciences
 National Academy of Sciences Miscellaneous Commercial ServicesCommercial Services National Academy of Sciences operates as a private, nongovernmental institution that advises on issues related to science and technology. It provides independent, objective analysis and advice and conducts other activities to solve complex problems and inform public policy decisions. The firm also encourages education and research, recognize outstanding contributions to knowledge, and increase public understanding in matters of science. The company was founded on March 3, 1863 and is headquartered in Washington, DC. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
American Academy of Arts & Sciences
 American Academy of Arts & Sciences Miscellaneous Commercial ServicesCommercial Services The American Academy of Arts & Sciences is an organization that honors excellence and brings together leaders. The non-profit company is based in Cambridge, MA. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree Doctorate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Graduate Degree Doctorate Degree Doctorate Degree | |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services The National Academy of Medicine (United States) is based in Washington and is focused on improving the health and well-being of individuals through various initiatives. These initiatives include the clinician well-being collaborative, which aims to accelerate the implementation of a national plan for health workforce well-being, and the development of a code of conduct for the use of artificial intelligence in health care. The organization also provides resources to support meaningful community engagement in health and health care programs and policies. Recently, the National Academy of Medicine announced the appointment of Mandy Cohen, a member of the organization, as the director of the Centers for Disease Control and Prevention. Additionally, the organization has released a publication celebrating 50 years of progress in biomedical science, health, and health care. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| AMGEN INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Tech/Sci/R&D Officer Consultant / Advisor | |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Director of Finance/CFO Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Howard Hughes Medical Institute, Inc.
 Howard Hughes Medical Institute, Inc. Investment Trusts/Mutual FundsMiscellaneous Howard Hughes Medical Institute, Inc. engages in the provision of biomedical research services and science education programs. It funds grants to both institutions and individuals in support of a wide range of science and research-related initiatives, including precollege and undergraduate science education, pre- and post-doctoral research fellowships, and international research activities. The company was founded by Howard R. Hughes in 1953 and is headquartered in Chevy Chase, MD. | Investment Trusts/Mutual Funds | Director/Board Member Director/Board Member Corporate Officer/Principal President Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Corporate Officer/Principal Doctorate Degree Masters Business Admin Undergraduate Degree Undergraduate Degree | |
| The University of Texas Southwestern Medical Center | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Doctorate Degree | |
| NGM BIOPHARMACEUTICALS, INC. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member Chief Tech/Sci/R&D Officer Consultant / Advisor | |
Kallyope, Inc.
 Kallyope, Inc. Medical/Nursing ServicesHealth Services Kallyope, Inc. engages in developing drugs and consumer products. Its specialties include biotechnology, gut-brain axis, nutrition, and pharmaceuticals. The company was founded by Thomas P. Maniatis, Charles Zuker and Richard Axel in 2014 and is headquartered in New York, NY. | Medical/Nursing Services | Founder Founder Director/Board Member Director/Board Member Chief Executive Officer | |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services California Institute of Technology provides education focusing on science, engineering, academia, business, and public service. The company was founded in 1891 and it is headquartered in Pasadena, CA. | College/University | Director/Board Member Director/Board Member Graduate Degree Doctorate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Chief Executive Officer Corporate Officer/Principal | |
| ORIC PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer Founder Director/Board Member | |
Atavistik Bio, Inc.
 Atavistik Bio, Inc. BiotechnologyHealth Technology Atavistik Bio, Inc. is a pre-clinical stage biotechnology company located in an undisclosed location. The American company is pioneering a synthetic, scalable approach to identify and harness highly conserved protein-metabolite interactions to revolutionize small molecule drug discovery. The company's advanced data analytics and AI platforms leverage structure-based drug design to engineer novel, highly specific small molecule drugs to activate, inhibit or stabilize targets. The company is led by an experienced management team and advisors, plus a robust investment syndicate, and is positioned to deliver transformational science to ultimately improve patient care. Atavistik Bio was founded by prominent scientists who are considered among the leading authorities in cell biology, cancer cell biology and cell metabolism. Bryan E Stuart has been the CEO of the company since 2023. | Biotechnology | Chief Executive Officer Director/Board Member Chairman Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
| PELOTON THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Executive Officer Chief Executive Officer Director/Board Member | |
| The Royal Society | Investment Trusts/Mutual Funds | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Plexium, Inc.
 Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| REGENERON PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
Ribon Therapeutics, Inc.
 Ribon Therapeutics, Inc. BiotechnologyHealth Technology Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member Director/Board Member Director/Board Member | |
| REVOLUTION MEDICINES, INC. | Pharmaceuticals: Other | Director/Board Member Director/Board Member Founder | |
Carmot Therapeutics, Inc.
 Carmot Therapeutics, Inc. BiotechnologyHealth Technology Carmot Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of therapeutics for metabolic diseases, cancer, and inflammation. Its pipeline includes CT-388, CT-996, and CT-868. The CT-388 refers to treatment taken once-weekly subcutaneous injectable for obesity and type 2 diabetes (T2D). The CT-996 comprises of once-daily oral treatment for obesity and T2D. The CT-868 consists of once-daily subcutaneous injectable for treatment of type 1 diabetes (T1D) patients with overweight or obesity. The company was founded in 2008 and is headquartered in Berkeley, CA. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
Circle Pharma, Inc.
 Circle Pharma, Inc. BiotechnologyHealth Technology Circle Pharma, Inc. provides biotechnology services. The company was founded by Matthew P. Jacobson and Scott Lokey in June 2014 and is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Stanford University School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Exonics Therapeutics, Inc.
 Exonics Therapeutics, Inc. BiotechnologyHealth Technology Exonics Therapeutics, Inc. develops therapies for neuromuscular diseases. It also develops gene editing technologies like CRISPR/Cas9 to permanently correct the majority of duchenne muscular dystrophy mutations. The company was founded by Eric N. Olson in February 2017 and is headquartered in Cambridge, MA. | Biotechnology | Director/Board Member Chairman Founder | |
| The University of Colorado | College/University | Doctorate Degree Graduate Degree Masters Business Admin | |
Nura Bio, Inc.
 Nura Bio, Inc. Pharmaceuticals: MajorHealth Technology Nura Bio, Inc. develops neuroprotective drugs. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member Founder Chief Executive Officer | |
| IMMUNE DESIGN CORP | Pharmaceuticals: Major | Director/Board Member Founder Director/Board Member | |
| SURROZEN, INC. | Biotechnology | Director/Board Member Director/Board Member Founder | |
Surrozen Operating, Inc.
 Surrozen Operating, Inc. BiotechnologyHealth Technology Surrozen Operating, Inc. operates as a biopharmaceutical company that focuses on harnessing the Wnt pathway for applications in regenerative medicine. The firm implements a surrogate Wnt platform with the potential to unlock stem cell control in an array of human tissues. The company was founded by K. Christopher Garcia, Roeland Nusse, Calvin J. Kuo, Hans Claudia and Claudia Janda in 2015 and is headquartered in South San Francisco, CA. | Biotechnology | Chairman Chief Executive Officer Founder | |
Neurona Therapeutics, Inc.
 Neurona Therapeutics, Inc. BiotechnologyHealth Technology Neurona Therapeutics, Inc. operates as a pre-clinical stage biotechnology company. It focuses on the discovery and development of cell-based therapies to treat intractable neurological disease. The company was founded by Arnold R. Kriegstein, John Rubenstein, Cory R. Nicholas, and Arturo Alvarez-Buylla and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| University of California San Diego | College/University | Undergraduate Degree Undergraduate Degree Corporate Officer/Principal | |
| CONSTELLATION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member | |
| Princeton University | College/University | Undergraduate Degree Undergraduate Degree | |
Artisan Partners LP
 Artisan Partners LP Investment ManagersFinance Artisan Partners LP (Artisan Partners) is a mutual fund manager and SEC-registered investment advisor headquartered in Milwaukee, Wisconsin. The firm was founded in 2009 by Andrew Ziegler and is a wholly-owned subsidiary of Artisan Partners Holdings LP, itself a subsidiary of Artisan Partners Asset Management, Inc. (NYSE: APAM). Artisan Partners serves as investment adviser to a variety of separately managed accounts, unregistered pooled investment vehicles, trustees of collective investment trusts, and to each series of Artisan Partners Funds, Inc. (Artisan Partners Funds) and Artisan Partners Global Funds plc (Artisan Partners Global Funds), an open-ended management investment company. | Investment Managers | Analyst-Equity Analyst-Equity | |
Aragon Pharmaceuticals, Inc.
 Aragon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Aragon Pharmaceuticals, Inc. develops biopharmaceutical products, It offers a pipeline of new anti-endocrine therapies targeting the biology of hormone resistant cancers. The company was founded by Charles L. Sawyers and Michael Jung on May 1, 2009 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Founder | |
| VIRIDIAN THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Founder | |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Graduate Degree Masters Business Admin | |
| ZYMERGEN INC. | Miscellaneous Commercial Services | Private Equity Investor Consultant / Advisor | |
| Rochester Christian University | College/University | Doctorate Degree Doctorate Degree | |
| INSEAD | College/University | Masters Business Admin Masters Business Admin | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Maze Therapeutics, Inc. is a is a biopharmaceutical company, which engages in the development of portfolio of therapeutic candidates for a number of genetically defined diseases. It focuses on translating genetic insights into new medicines by utilizing an approach that combines the analysis of large-scale human genetics data, cutting-edge functional genomics, and an array of drug discovery approaches. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman in 2018 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| BIOGEN INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
OrbiMed Capital LLC
 OrbiMed Capital LLC Financial ConglomeratesFinance Part of OrbiMed Advisors LLC, OrbiMed Capital LLC is a company based in New York, NY. | Financial Conglomerates | Corporate Officer/Principal Private Equity Analyst | |
| ATYR PHARMA, INC. | Pharmaceuticals: Major | President Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Corporate Officer/Principal Doctorate Degree |
Statistik
International
| Vereinigte Staaten | 48 |
| Belgien | 2 |
| Vereinigtes Königreich | 2 |
| Frankreich | 2 |
Sektoral
| Health Technology | 27 |
| Consumer Services | 13 |
| Commercial Services | 7 |
| Finance | 4 |
| Miscellaneous | 3 |
Operativ
| Director/Board Member | 436 |
| Corporate Officer/Principal | 270 |
| Founder | 110 |
| Independent Dir/Board Member | 100 |
| Undergraduate Degree | 88 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Robin Washington | 34 |
| Michael Wyzga | 31 |
| Iain Dukes | 30 |
| Erez Chimovits | 30 |
| Dror Berman | 29 |
| Carolyn Bertozzi | 28 |
| Richard Scheller | 27 |
| David Goeddel | 27 |
| Larry Lasky | 27 |
| David Baltimore | 27 |
| Jennifer Doudna | 26 |
| Kenneth Frazier | 26 |
| Peter Svennilson | 25 |
| Steven James | 24 |
- Börse
- Insiders
- Leon E. Chen
- Unternehmensverbindungen
